This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $810,032 to Michigan State University to conduct research on neurobiological mechanisms to alleviate comorbid pain and obesity. The research will take place at Michigan State University's campus in East Lansing, Michigan and is expected to be completed by August 31, 2027. No details were provided on any sub-award recipients or services delivered under the grant.